Global Oligonucleotide Synthesis Market Growth (Status and Outlook) 2023-2029

Global Oligonucleotide Synthesis Market Growth (Status and Outlook) 2023-2029

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.

LPI (LP Information)' newest research report, the “Oligonucleotide Synthesis Industry Forecast” looks at past sales and reviews total world Oligonucleotide Synthesis sales in 2022, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Synthesis sales for 2023 through 2029. With Oligonucleotide Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Synthesis industry.

This Insight Report provides a comprehensive analysis of the global Oligonucleotide Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide Synthesis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Synthesis and breaks down the forecast by type, by end user, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Synthesis.

The global Oligonucleotide Synthesis market size is projected to grow from US$ 1815.9 million in 2022 to US$ 2847.8 million in 2029; it is expected to grow at a CAGR of 6.6% from 2023 to 2029.

Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.

This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Synthesis market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Custom Oligonucleotides
Pre-designed Oligonucleotides

Segmentation by end user
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Integrated DNA Technologies
Merck
Eurofins Genomics
Thermo Fisher Scientific
Agilent Technologies
Eurogentec
GE Healthcare
LGC Biosearch Technologies
Nitto Denko Avecia
Genscript
Genedesign
TriLink Biotechnologies
Bio-Synthesis
ATDBio

Please note: The report will take approximately 2 business days to prepare and deliver.